About

ST-segment elevation myocardial infarction (STEMI) remains a leading cause of morbidity and mortality. Challenges in diagnosis remain due to variability in ECG presentation, conditions with similar presentations, variability in the electrical manifestation of ST-segment elevation on ECG, and systems issues with access to rapid diagnosis that can make this diagnosis challenging.

Given the significant morbidity and mortality associated with STEMI, there has been a push to improve the timely diagnosis of STEMI to ensure patients receive therapy faster. However, there remain challenges in diagnosis.

Articles

Platelet Function Testing in Clinical Practice - Experience and Views from Europe and the US

Citation:

European Cardiology 2011;7(3):203–11

Barriers to Implementation of Primary Percutaneous Coronary Intervention in Europe

Citation:

European Cardiology 2011;7(2):108–12

Latest Strategies and Patient Outcomes in the Treatment of ST-segment-elevation Myocardial Infarction

Citation:

European Cardiology 2010;6(1):80–2

Antiplatelet Therapy in Acute Coronary Syndromes

Citation:

European Cardiology 2010,6(1):58–61